FDA proposes relocation of Office of Dietary Supplement Programs, industry reacts - Food Navigator USA

The dietary supplement industry is expressing concern over a proposed update to a Food and Drug Administration (FDA) reorganization that would relocate the current Office of Dietary Supplement Programs (ODSP) to a new office under its “Risk Management Functions”.

Read more

FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska - Q&A with FDA Podcast

Welcome to another episode of our podcast series, “Q&A with FDA”, from the FDA’s Division of Drug Information, where we answer some of the most frequently asked questions that we’ve received. In a previous episode, we discussed FDA’s Overdose Prevention Framework with Dr.